Closed
The Marked Chart Wire · Business
Biogen
Biogen revised its full-year 2026 adjusted earnings per share outlook to a range of $15.95 to $16.75, down from the previous $15.85 to $16.85. The new midpoint sits above the $12.36 analyst estimate.
Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
HotGE Vernova
GE Vernova posted higher third-quarter earnings and sales, driven by strong performance in its power and electrification divisions. The firm also increased its full-year guidance and expanded its stock repurchase program.
GE HealthCare
The company reported non-GAAP earnings of $1.34 per share, exceeding expectations by $0.14. Revenue reached $5.51 billion, topping forecasts by $160 million, while management increased its annual guidance.
Meta
Meta shares dropped 11 percent last week after Q3 results showed negative free cash flow and a proposed $97 billion asset sale. Canaccord analysts maintain a positive outlook on the stock.
Stellantis
The European automaker disclosed a 4 billion euro cash drain during the period as it executes its ongoing turnaround strategy.
UMC Earnings
The chipmaker reported third-quarter earnings per share of $0.21, below the $0.23 expected by analysts. Revenue came in at $2.32 billion, falling short of the $2.35 billion forecast.
Robinhood
The firm's quarterly revenue matched forecasts, boosted by expansion into options and prediction markets. However, falling crypto prices reduced overall profits, countering gains from these newer service lines.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.